Company: CCIXW
Filing Date: 2025-12-05
Form Type: S-4/A
Source: 0001193125-25-309933
Chunk: 237

Company: Churchill Capital Corp IX/Cayman
Filing Date: 2025-12-05
Form: S-4/A
Chunk 237
---
 proposal or other proposals (as described in this proxy statement/prospectus) at the extraordinary general meeting.

In the event that the aggregate cash consideration that CCIX would be required to pay for all shares of CCIX public shares that are validly submitted for redemption, plus any amount required to satisfy the foregoing cash condition pursuant to the terms of the Merger Agreement, exceeds the aggregate amount of cash available to CCIX, CCIX may not complete the business combination or redeem any shares, and all shares of CCIX public shares submitted for redemption will be returned to the holders thereof and CCIX may instead search for an alternate business combination.

Public shareholders, together with any affiliates of theirs or any other person with whom they are acting in concert or as a “group,” will be restricted from seeking redemption rights with respect to more than 15% of the public shares.

The CCIX current articles of association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13(d) of the Exchange Act), will be restricted from redeeming in the aggregate his, her or its shares or, if part of such a group, the group’s shares, in excess of 15% of the CCIX public shares unless such shareholder first obtains CCIX’s prior consent (the “Excess Shares”). Your inability to redeem Excess Shares will reduce your influence over CCIX’s ability to consummate the business combination and you could suffer a material loss on your investment in CCIX if you sell such excess shares in open market transactions.

Additionally, you will not receive redemption distributions with respect to such excess shares if CCIX consummates the business combination. As a result, you will continue to hold that number of shares aggregating to more than 15% of the shares sold in the CCIX IPO and, in order to dispose of such excess shares, would be required to sell your stock in open market transactions, potentially at a loss. CCIX cannot assure you that the value of such excess shares will appreciate over time following the business combination or that the market price of CCIX public shares will exceed the per-share redemption price. Notwithstanding the foregoing, shareholders may challenge CCIX’s determination as to whether a shareholder is acting in concert or as a group with another shareholder in a court of competent jurisdiction.

However, CCIX’s shareholders’ ability to vote all of their shares (including Excess Shares) for or against the business combination is not restricted